CTRI/2021/03/032343尚未招募未知
Definitive Chemoradiotherapy in Esophageal Cancer using Volumetric Modulated Arc Therapy (VMAT) Technique: A Report on Clinical Outcomes
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- one
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Histologically confirmed non-recurrent non-metastatic squamous cell carcinoma or adenocarcinoma of esophagus or gastroesophageal junction (GEJ).
- •2. Patients must be considered as having inoperable/unresectable tumor, considered to be unfit for surgery and/or are unwilling for surgery.
- •3. ECOG performance status less than or equal to 2.
- •4. Adequate baseline bone marrow, liver and renal functions as determined by routine standard-of-care tests.
- •5. Patients being treated using VMAT technique.
- •6. Willingness to participate in the study and provides a voluntary informed consent.
排除标准
- •1. Metastatic disease at presentation.
- •2. History of prior mediastinal/thoracic malignancy or condition that warranted irradiation or chemotherapy.
- •3. Patients with tracheoesophageal fistula/bronchoesophageal fistula.
- •4. Patients with active second malignancy.
- •5. Uncontrolled co-morbidities that would hamper the patientsâ?? adherence to treatment.
- •6. Known contraindications to use of concurrent chemotherapy (E.g.: impaired renal/hematological function, known hypersensitivity, etc.)
研究者
相似试验
进行中（未招募）
不适用
Oesophageal squamous cell cancer: chemoradiotherapy versus chemotherapy and surgery - a feasibility study - Feasibility trial of chemoradiation or surgery for oesophageal canceroesophageal cancerMedDRA version: 12Level: LLTClassification code 10030151Term: Oesophageal cancerEUCTR2009-013877-16-GBniversity Hospitals Bristol NHS Foundation Trust
进行中（未招募）
1 期
Eoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusCTIS2022-500966-82-00Karolinska University Hospital1,010
进行中（未招募）
1 期
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864EUCTR2020-000149-15-IEKarolinska University Hospital1,020
进行中（未招募）
1 期
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864EUCTR2020-000149-15-SEKarolinska University Hospital1,020
进行中（未招募）
1 期
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864EUCTR2020-000149-15-NOKarolinska University Hospital1,020